Subcutaneous venous port implantation in patients with bilateral breast surgery.
The purpose of this study was to evaluate the long-term follow-up results of subcutaneous venous ports implanted in patients with bilateral mastectomies. We retrospectively reviewed the hospital charts and the electronic database of 17 patients with bilateral mastectomies whom had venous port implantation in our interventional radiology suit. A total of 17 ports were implanted to the paramedian (n = 3) and anterolateral (standard; n = 12) chest wall, on the trapezius muscle (n = 1), and to the antecubital fossa (n = 1). The mean age was 48.29 years (range: 35-60 years). The mean time interval from time of surgery to port implantation was 34 months (range: 1-84 months). The mean follow-up time was 15 months (range: 7-39 months). Follow-up parameters and classification of the complications was defined according to the SIR guidelines. No procedure-related complication occurred. A single case of mild late infection was noted and the infection rate was 0.19/1000 catheter days. Infusion chemotherapy administration was still going on in eight patients. Two patients died during the follow-up and four patients were lost after 6 months. Port removal was performed in three patients at follow-up because of the end of treatment. One trapezius port and one paramedian port weres among the removed ports without any problem. Although we have a limited number of patients, port placement to the anterior chest wall, either paramedian or anterolateral, on the trapezius muscle or to the antecubital fossa depending on the extent of the bilateral breast surgeries that can be performed with low complication rates by a careful patient and anatomical location selection by involving the patients in the decision-making process. We believe that patient education and knowledge of possible complications have high importance in follow-up.
Peynircioglu
Bora
B
Department of Radiology, Hacettepe University, School of Medicine, Ankara, Turkey. borapeynir@gmail.com
Arslan
E Bengi
EB
Cil
Barbaros E
BE
Geyik
Serdar
S
Hazirolan
Tuncay
T
Konan
Ali
A
Balkanci
Ferhun
F
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery; D002408:Catheters, Indwelling; D002481:Cellulitis / Q000000981:diagnostic imaging / Q000209:etiology; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D020878:Device Removal; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D008209:Lymphedema / Q000000981:diagnostic imaging / Q000209:etiology; D015411:Mastectomy, Modified Radical; D015409:Mastectomy, Radical; D015413:Mastectomy, Simple; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery; D011859:Radiography; D012189:Retrospective Studies